PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

25 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
1.
Herold, J.M.* et al.: Population-based reference values for kidney function and kidney function decline in 25- to 95-year-old Germans without and with diabetes. Kidney Int., DOI: 10.1016/j.kint.2024.06.024 (2024)
2.
Zimmermann, S.* et al.: Chronic kidney disease leads to microglial potassium efflux and inflammasome activation in the brain. Kidney Int., DOI: 10.1016/j.kint.2024.06.028 (2024)
3.
Riedhammer, K.M.* et al.: Implication of transcription factor FOXD2 dysfunction in syndromic congenital anomalies of the kidney and urinary tract (CAKUT). Kidney Int. 105, 844-864 (2023)
4.
Bissinger, R.* ; Bohnert, B.N. ; Nemkov, T.* & Artunc, F.: The authors reply. Kidney Int. 101, 649-650 (2022)
5.
Drovandi, S.* et al.: Variation of the clinical spectrum and genotype-phenotype associations in Coenzyme Q10 deficiency associated glomerulopathy. Kidney Int. 102, 592-603 (2022)
6.
Drovandi, S.* et al.: Oral Coenzyme Q10 supplementation leads to better preservation of kidney function in steroid-resistant nephrotic syndrome due to primary Coenzyme Q10 deficiency. Kidney Int. 102, 604-612 (2022)
7.
Gorski, M.* et al.: Genetic loci and prioritization of genes for kidney function decline derived from a meta-analysis of 62 longitudinal genome-wide association studies. Kidney Int. 102, 624-639 (2022)
8.
Bissinger, R.* et al.: Proteinuric chronic kidney disease is associated with altered red blood cell lifespan, deformability and metabolism. Kidney Int. 100, 1227-1239 (2021)
9.
Bohnert, B.N. et al.: The Case | A 74-year-old liver transplant recipient with nephrotic-range proteinuria. Kidney Int. 99, 1031-1032 (2021)
10.
Gorski, M.* et al.: Meta-analysis uncovers genome-wide significant variants for rapid kidney function decline. Kidney Int. 99, 926-939 (2021)
11.
Artunc, F.: Kidney-derived PCSK9-a new driver of hyperlipidemia in nephrotic syndrome? Kidney Int. 98, 1393-1395 (2020)
12.
Pastor-Arroyo, E.M.* et al.: The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk. Kidney Int. 94, 49-59 (2018)
13.
Bohnert, B.N. et al.: Aprotinin prevents proteolytic epithelial sodium channel (ENaC) activation and volume retention in nephrotic syndrome. Kidney Int. 93, 159-172 (2017)
14.
Gorski, M.* et al.: Genome-wide association study of kidney function decline in individuals of European descent. Kidney Int. 87, 1017–1029 (2015)
15.
Seleznik, G.M.* et al.: The lymphotoxin β receptor is a potential therapeutic target in renal inflammation. Kidney Int. 89, 113–126 (2015)
16.
Pattaro, C.* et al.: Genome-wide linkage analysis of serum creatinine in three isolated European populations. Kidney Int. 76, 297-306 (2009)
17.
Segerer, S.* et al.: Compartment specific expression of dendritic cell markers in human glomerulonephritis. Kidney Int. 74, 37-46 (2008)
18.
Frischmann, M.E.* et al.: In vivo turnover study demonstrates diminished clearance of lipoprotein(a) in hemodialysis patients. Kidney Int. 71, 1036-1043 (2007)
19.
Kollerits, B.* ; Fliser, D.* ; Heid, I.M. ; Ritz, E.* & Kronenberg, F.*: Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: The Mild to Moderate Kidney Disease Study. Kidney Int. 71, 1279-1286 (2007)
20.
Segerer, S.* et al.: Expression of the chemokine receptor CXCR1 in human glomerular disease. Kidney Int. 69, 1765-1773 (2006)
▮◀ ◀◀ 1 ... 2 ... ▶▶ ▶▮